An independent review has found that New Zealand's Pharmac needs to make significant organisational changes over the next five years to meet public and stakeholder expectations.
-
Latest News
These system-shifting therapies come along every few years, but this is different
Every five to ten years, a therapy or group of therapies emerge from company pipelines, providing particular challenges for Australia's policymakers. They are almost always reimbursed, but it generally takes time and is often accompanied by wider changes.
-
Latest News Culture review delivers a scathing assessment of New Zealand's Pharmac April 29, 2025
-
Latest News Pfizer-commissioned survey reveals rising GP concerns over medical misinformation April 29, 2025According to the survey, 97 per cent of GPs agreed they were concerned about the influence of medical misinformation, having seen a shift in attitudes and behaviour amongst their patient community.
-
Latest News ‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer April 29, 2025A world-first clinical trial launched in Melbourne is being hailed as a potential ‘game-changer’ for the way people with bowel cancer are treated.
-
Latest News New survey confirms significant interest in accessing weight loss therapies April 28, 2025According to Bupa's annual Pulse Check, based on a survey of 2,000 people, almost one in five, equating to around four million people, said they would consider prescription medicines for weight loss.
-
Latest News Medicines Australia announces appointment of communications director April 28, 2025Medicines Australia has announced the appointment of Rachael Coghlan as its communications director and a new executive team member.
-
Latest News Stakeholders welcome the PBS listing of AbbVie's blood cancer therapy April 28, 2025Sharon Winton, the CEO and director of Lymphoma Australia, said, “Patients living with DLBCL deserve options at every stage of their treatment journey. The availability of another treatment option for patients who have already undergone two or more lines of therapy acknowledges this need and is welcomed by the community.”
-
Latest News March PBAC delivers outcome for high profile pre-funded cancer therapy April 27, 2025At its March meeting, surrounded by controversy following the decision to defer multiple submissions, the Pharmaceutical Benefits Advisory Committee delivered recommendations for high-profile cancer therapies, including one funded outside the PBS before it was approved, and several treatments for a chronic autoimmune disease.
-
Latest News Government funding for new nasal spray ends three-decade drought April 27, 2025Joana De Castro, the managing director of Johnson & Johnson Innovative Medicine, said the PBS listing is “long overdue.”
-
Latest News Repurposed diabetes drug could deliver gains for people living with major joint pain April 27, 2025Research led by Monash University has found that a commonly used diabetes medicine can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements.
-
Podcast The Dispatched Podcast 'Week/s in Review' - 24 April April 23, 2025The health election debate mainly concerned bulk billing. New bureaucracies are rarely the solution to anything, and the challenge of faster funded access to new health technologies, particularly when advisory committees with power appear opposed. The complexity of weight-loss therapies presents opportunities.
-
Latest News TGA approves new indication for GSK's RSV vaccine April 24, 2025“For adults over 50 who live with the challenges of chronic health diseases, like COPD and asthma, RSV can be extremely serious,” said Mark Brooke, the CEO of Lung Foundation Australia.
-
Latest News It's important to understand that health technology assessment is not an enabler April 24, 2025This publication has and will continue to argue that processes like the HTA review simply cannot deliver the reform people expect because it's not an enabling policy framework. It will deliver targeted adjustments to the access barrier. Is that what stakeholders want?
-
Latest News US trade agenda looks mostly disinterested in pharmaceuticals April 23, 2025The release of the Trump administration's terms of reference for its trade negotiations with India has revealed no significant interest in pharmaceutical issues, despite the country's standing as one of the worst offenders on intellectual property protection.
-
Latest News Roche announces historic investment to build US manufacturing base April 23, 2025Roche has announced it will invest US$50 billion in the US over the next few years in a move that appears aimed at mitigating the risk of tariffs.
-
Latest News 'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative' April 23, 2025Pfizer has launched Part of the Story to mark World Book Day today, advocating a global campaign to help reimagine traditional cancer narratives and keep pace with science.
-
Latest News A mixed bag for the industry in Trump executive order on medicine pricing April 17, 2025The US biopharmaceutical industry will welcome the Trump administration's move to scrap the so-called 'pill penalty' introduced as part of the Biden administration's Inflation Reduction Act but will be less supportive of other proposed measures.
-
Australian Biotech UQ tests vaccine response in CEPI-backed 150-day ‘moonshot’ challenge April 16, 2025Researchers at the University of Queensland are attempting to create a vaccine in just 150 days to demonstrate their ability to respond to a pandemic as part of a program backed by the Coalition for Epidemic Preparedness Innovations.
-
Australian Biotech Australian research finds turning off protein may help prevent liver cancer April 16, 2025New research from the Sydney-based Centenary Institute has found that switching off a specific protein in liver cells could help prevent the early development of liver cancer.
-
Latest News Investors appear comfortable as Trump administration says pharma tariffs coming April 16, 2025Investors have shrugged off concerns over US President Donald Trump's planned tariffs on pharmaceutical imports with CSL's share price closing up over 2 per cent yesterday.
Australian Biotech
-
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 -
Radiopharm Theranostics doses first patient in US Phase 2b imaging study of brain metastasis
April 28, 2025 -
Dimerix says FDA confirms proteinuria as acceptable endpoint for DMX-200 Phase 3 trial
April 28, 2025 -
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 -
Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial
April 22, 2025
Other Health
-
Kidney Health Australia urges those at risk to get checked
March 10, 2025 -
Sepsis survivors at high risk after hospital discharge, new figures reveal
March 5, 2025 -
New Zealand medtech start-up Avasa hits milestone in development of world’s first arterial coupler
February 24, 2025 -
Australia isn’t ready for the next cardiac epidemic, warns landmark heart valve disease report
February 17, 2025 -
BTC announced new partnership agreement with Corcym
December 9, 2024
Latest Video
New Stories
-
‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer
April 29, 2025 - - Latest News -
These system-shifting therapies come along every few years, but this is different
April 29, 2025 - - Latest News -
Culture review delivers a scathing assessment of New Zealand's Pharmac
April 29, 2025 - - Latest News -
Pfizer-commissioned survey reveals rising GP concerns over medical misinformation
April 29, 2025 - - Latest News -
New survey confirms significant interest in accessing weight loss therapies
April 28, 2025 - - Latest News -
Medicines Australia announces appointment of communications director
April 28, 2025 - - Latest News -
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - - Australian Biotech